|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000003147 |
Summary for ICA1 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000003147 | Gene symbol | ICA1 |
| Gene name | islet cell autoantigen 1 | |
| HGNC | 5343 | |
| Entrez ID | 3382 | |
| Gene type | protein_coding | |
| Synonyms | ICA1|ICAp69|ICA69 | |
| UniProtAcc | Q05084 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ICA1 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ICA1 | 3.25e+02 | -1.60e+00 | 2.70e-01 | -5.92e+00 | 3.17e-09 | 1.73e-08 | HNSC |
| ICA1 | 2.42e+03 | 1.05e+00 | 1.37e-01 | 7.63e+00 | 2.29e-14 | 2.43e-13 | COAD |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ICA1 | 2.39e+03 | 1.31e+00 | 2.40e-01 | 5.45e+00 | 5.03e-08 | 6.38e-07 | READ |
Top |
Sex-biased somatic mutation for ICA1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ICA1 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| SARC | cg00507727 | chr7:8262561 | CGI:chr7:8261401-8262622 | UTR,promoter,exon,gene body | 2.26e-01 | 1.25e-01 | 2.15e+00 | 3.13e-02 | 3.80e-02 | 1.02e-01 |
| SARC | cg10798171 | chr7:8262671 | CGI:chr7:8261401-8262622 | UTR,promoter,exon,gene body | 3.50e-01 | 2.36e-01 | 3.79e+00 | 1.50e-04 | 7.28e-04 | 1.14e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| HNSC | cg11837701 | chr7:8263269 | CGI:chr7:8261401-8262622 | promoter | 6.86e-01 | 7.91e-01 | -2.08e+00 | 3.74e-02 | 3.91e-02 | -1.05e-01 |
| COAD | cg16379704 | chr7:8262621 | CGI:chr7:8261401-8262622 | UTR,promoter,exon,gene body | 1.75e-01 | 3.05e-01 | -4.85e+00 | 1.25e-06 | 1.37e-05 | -1.29e-01 |
| COAD | cg20641531 | chr7:8263101 | CGI:chr7:8261401-8262622 | promoter | 5.84e-01 | 7.16e-01 | -2.35e+00 | 1.86e-02 | 2.34e-02 | -1.31e-01 |
| COAD | cg11837701 | chr7:8263269 | CGI:chr7:8261401-8262622 | promoter | 4.64e-01 | 5.78e-01 | -2.14e+00 | 3.27e-02 | 3.62e-02 | -1.14e-01 |
| BLCA | cg11837701 | chr7:8263269 | CGI:chr7:8261401-8262622 | promoter | 5.28e-01 | 7.03e-01 | -2.04e+00 | 4.10e-02 | 4.29e-02 | -1.74e-01 |
| LIHC | cg05434957 | chr7:8261805 | CGI:chr7:8261401-8262622 | promoter,gene body | 1.69e-01 | 6.25e-02 | 2.35e+00 | 1.90e-02 | 2.14e-02 | 1.07e-01 |
| LIHC | cg20371765 | chr7:8262641 | CGI:chr7:8261401-8262622 | UTR,promoter,exon,gene body | 4.03e-01 | 2.35e-01 | 2.46e+00 | 1.40e-02 | 1.64e-02 | 1.69e-01 |
| LIHC | cg11837701 | chr7:8263269 | CGI:chr7:8261401-8262622 | promoter | 7.63e-01 | 8.99e-01 | -2.63e+00 | 8.57e-03 | 1.06e-02 | -1.35e-01 |
| KIRP | cg16379704 | chr7:8262621 | CGI:chr7:8261401-8262622 | UTR,promoter,exon,gene body | 2.13e-01 | 3.16e-01 | -4.58e+00 | 4.74e-06 | 1.99e-05 | -1.03e-01 |
| CHOL | cg05822926 | chr7:8262605 | CGI:chr7:8261401-8262622 | UTR,promoter,exon,gene body | 1.40e-01 | 2.85e-01 | -3.02e+00 | 2.51e-03 | 1.19e-02 | -1.45e-01 |
| CHOL | cg16379704 | chr7:8262621 | CGI:chr7:8261401-8262622 | UTR,promoter,exon,gene body | 1.91e-01 | 3.75e-01 | -3.17e+00 | 1.52e-03 | 1.07e-02 | -1.84e-01 |
| CHOL | cg20371765 | chr7:8262641 | CGI:chr7:8261401-8262622 | UTR,promoter,exon,gene body | 1.17e-01 | 2.29e-01 | -2.14e+00 | 3.25e-02 | 3.87e-02 | -1.12e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg13394022 | chr7:8263201 | CGI:chr7:8261401-8262622 | promoter | 7.57e-01 | 8.99e-01 | -4.70e+00 | 2.59e-06 | 4.62e-06 | -1.42e-01 |
| BRCA | cg11837701 | chr7:8263269 | CGI:chr7:8261401-8262622 | promoter | 5.65e-01 | 8.16e-01 | -7.59e+00 | 3.16e-14 | 1.08e-13 | -2.51e-01 |
| HNSC | cg05822926 | chr7:8262605 | CGI:chr7:8261401-8262622 | UTR,promoter,exon,gene body | 3.34e-01 | 1.86e-01 | 2.35e+00 | 1.86e-02 | 2.64e-02 | 1.48e-01 |
| HNSC | cg10798171 | chr7:8262671 | CGI:chr7:8261401-8262622 | UTR,promoter,exon,gene body | 2.21e-01 | 9.60e-02 | 2.65e+00 | 8.13e-03 | 1.67e-02 | 1.25e-01 |
| HNSC | cg20641531 | chr7:8263101 | CGI:chr7:8261401-8262622 | promoter | 7.97e-01 | 9.24e-01 | -2.57e+00 | 1.02e-02 | 1.88e-02 | -1.27e-01 |
Top |
Exon skipping events with PSI in TCGA for ICA1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for ICA1 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ICA1 |
| TFs related to ICA1. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| SKCM | BARX2 | ICA1 | 3.58e+00 | 5.92e-03 | 4.73e+00 | 9.84e-01 | Female-biased |
| SKCM | FOXA1 | ICA1 | 2.95e+00 | 2.66e-03 | 4.34e+00 | 9.81e-01 | Female-biased |
| SKCM | FOXA2 | ICA1 | 3.17e+00 | 4.45e-03 | 4.40e+00 | 9.80e-01 | Female-biased |
| SKCM | FOXB1 | ICA1 | 3.02e+00 | 2.96e-03 | 4.37e+00 | 9.81e-01 | Female-biased |
| SKCM | SRY | ICA1 | 3.72e+00 | 7.33e-03 | 4.79e+00 | 9.84e-01 | Female-biased |
| SKCM | ZNF211 | ICA1 | 4.79e+00 | 1.42e-02 | 5.66e+00 | 9.83e-01 | Female-biased |
| SKCM | ZNF25 | ICA1 | 2.82e+00 | 1.89e-03 | 4.31e+00 | 9.81e-01 | Female-biased |
| SKCM | ZNF334 | ICA1 | 2.91e+00 | 9.82e-04 | 4.59e+00 | 9.87e-01 | Female-biased |
| SKCM | ZNF418 | ICA1 | 2.65e+00 | 3.50e-04 | 4.62e+00 | 9.88e-01 | Female-biased |
| SKCM | ZNF580 | ICA1 | 3.41e+00 | 4.30e-03 | 4.65e+00 | 9.85e-01 | Female-biased |
| SKCM | ZNF79 | ICA1 | 2.74e+00 | 1.18e-03 | 4.37e+00 | 9.83e-01 | Female-biased |
| ICA1 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for ICA1 |
| RBPs related to ES in ICA1. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | SAMD4A | exon_skip_473748 | 7.90e+00 | 1.54e-03 | 8.45e+00 | 9.92e-01 | Female-biased |
| UVM | SAMD4A | exon_skip_473748 | 8.22e+00 | 9.85e-01 | 7.90e+00 | 7.04e-03 | Male-biased |
| THYM | SAMD4A | exon_skip_473748 | 8.49e+00 | 9.91e-01 | 8.04e+00 | 2.48e-03 | Male-biased |
| LUSC | SAMD4A | exon_skip_473748 | 8.28e+00 | 7.71e-03 | 8.66e+00 | 9.87e-01 | Female-biased |
| CHOL | PABPC3 | exon_skip_473747 | 7.90e+00 | 5.41e-03 | 8.39e+00 | 9.87e-01 | Female-biased |
| CHOL | SAMD4A | exon_skip_473748 | 7.97e+00 | 4.96e-03 | 8.46e+00 | 9.88e-01 | Female-biased |
| CHOL | ZFP36 | exon_skip_473770 | 6.14e+00 | 2.85e-03 | 6.72e+00 | 9.81e-01 | Female-biased |
| KIRP | SAMD4A | exon_skip_473748 | 7.82e+00 | 1.09e-02 | 8.14e+00 | 9.81e-01 | Female-biased |
| BRCA | SAMD4A | exon_skip_473748 | 7.97e+00 | 9.82e-01 | 7.38e+00 | 8.94e-03 | Male-biased |
| THCA | RBM24 | exon_skip_473751 | 1.06e+01 | 9.91e-01 | 1.03e+01 | 7.80e-03 | Male-biased |
| THCA | RBM24 | exon_skip_473768 | 8.70e+00 | 9.91e-01 | 8.32e+00 | 3.18e-03 | Male-biased |
| THCA | SAMD4A | exon_skip_473748 | 8.44e+00 | 9.89e-01 | 8.09e+00 | 4.25e-03 | Male-biased |
| PCPG | RBM24 | exon_skip_473751 | 1.03e+01 | 4.97e-03 | 1.06e+01 | 9.94e-01 | Female-biased |
| MESO | KHDRBS2 | exon_skip_473746 | 1.01e+01 | 1.32e-03 | 1.07e+01 | 9.97e-01 | Female-biased |
| MESO | RBM24 | exon_skip_473751 | 1.02e+01 | 2.74e-03 | 1.06e+01 | 9.96e-01 | Female-biased |
| LGG | SAMD4A | exon_skip_473748 | 8.63e+00 | 9.93e-01 | 8.12e+00 | 1.66e-03 | Male-biased |
| GBM | PABPC3 | exon_skip_473747 | 8.00e+00 | 1.08e-02 | 8.33e+00 | 9.82e-01 | Female-biased |
| PAAD | ZC3H10 | exon_skip_473747 | 7.54e+00 | 9.89e-01 | 7.08e+00 | 1.30e-03 | Male-biased |
| KIRC | PABPC3 | exon_skip_473747 | 7.93e+00 | 9.91e-03 | 8.24e+00 | 9.83e-01 | Female-biased |
| KIRC | RBM24 | exon_skip_473751 | 1.01e+01 | 2.85e-03 | 1.05e+01 | 9.96e-01 | Female-biased |
| KIRC | SAMD4A | exon_skip_473748 | 8.15e+00 | 6.99e-03 | 8.49e+00 | 9.87e-01 | Female-biased |
| BLCA | SAMD4A | exon_skip_473748 | 7.76e+00 | 9.45e-04 | 8.36e+00 | 9.92e-01 | Female-biased |
| ICA1 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10268598 | chr7:8121897:C:T | gene | 0.0798114609204622 | 0.043004328050982 | LGG | Female-baised eQTL |
| rs17581161 | chr7:13614574:A:G | - | -0.0930826763545959 | 0.0226530928478076 | COAD | Female-baised eQTL |
| rs12533526 | chr7:13615108:A:C | - | -0.0925246570905387 | 0.0239430697459771 | COAD | Female-baised eQTL |
| rs73062546 | chr7:13616547:C:G | - | -0.0915834126069661 | 0.0277137536896176 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs302135 | chr7:18255732:A:G | - | -0.0457524742356462 | 0.037389825509491 | KIRC | Male-baised eQTL |
| rs11773416 | chr7:4507238:C:T | - | 0.0386559364526091 | 0.0392937042193867 | KIRC | Male-baised eQTL |
| rs17138794 | chr7:18222650:A:T | - | 0.0454286815494785 | 0.0403765213469895 | KIRC | Male-baised eQTL |
| rs302142 | chr7:18242202:A:G | - | -0.0450077982754647 | 0.0459135207106412 | KIRC | Male-baised eQTL |
| rs17418362 | chr7:18229713:T:C | - | 0.0450270873452089 | 0.0470385673769879 | KIRC | Male-baised eQTL |
| rs2098214 | chr7:15070961:A:T | - | 0.100652678341913 | 0.00373603575228102 | BLCA | Male-baised eQTL |
| rs28735425 | chr7:15070624:T:C | - | 0.10055965065925 | 0.00389023496910769 | BLCA | Male-baised eQTL |
| rs10479944 | chr7:15074211:T:A | - | 0.0861703896856599 | 0.0214968041875458 | BLCA | Male-baised eQTL |
| rs17168652 | chr7:15084985:A:G | - | 0.0977872697369186 | 0.0268925993380599 | BLCA | Male-baised eQTL |
| rs17168654 | chr7:15085122:G:A | - | 0.0977872697369186 | 0.0268925993380599 | BLCA | Male-baised eQTL |
| rs72583082 | chr7:15083700:A:G | - | 0.0975986143575682 | 0.027237652636022 | BLCA | Male-baised eQTL |
| rs72583073 | chr7:15076703:T:C | - | 0.0973918023519766 | 0.0275295030344872 | BLCA | Male-baised eQTL |
| rs11761802 | chr7:5789519:C:G | - | -0.0626952158273135 | 0.028381759168566 | BLCA | Male-baised eQTL |
| rs72583077 | chr7:15079714:A:T | - | 0.0965729302458767 | 0.0303761598643526 | BLCA | Male-baised eQTL |
| rs10277424 | chr7:14756156:C:A | - | 0.0845899408602863 | 0.0379911952267958 | BLCA | Male-baised eQTL |
| rs17168390 | chr7:14754467:T:A | - | 0.0855810755031308 | 0.0382101751912624 | BLCA | Male-baised eQTL |
| rs79396525 | chr7:14759371:C:T | - | 0.0847312078988585 | 0.0420944305715303 | BLCA | Male-baised eQTL |
| rs9886266 | chr7:14763365:T:G | - | 0.0840811485540385 | 0.045556335499664 | BLCA | Male-baised eQTL |
| rs10242452 | chr7:2094981:A:G | - | 0.118661419081491 | 0.00896493875460136 | COAD | Male-baised eQTL |
| rs10950449 | chr7:13295416:G:C | - | 0.0588544412778447 | 0.0196134350498473 | COAD | Male-baised eQTL |
| rs4721164 | chr7:1892993:C:G | - | 0.0572170475533516 | 0.030076169692002 | COAD | Male-baised eQTL |
| rs55944228 | chr7:3707602:G:A | - | 0.103841122842064 | 0.0322715669060506 | COAD | Male-baised eQTL |
| rs10250562 | chr7:3707203:T:C | - | 0.102514070477653 | 0.0329754270698282 | COAD | Male-baised eQTL |
| rs11762803 | chr7:1847169:A:G | - | 0.0604742783988722 | 0.0347785005815631 | COAD | Male-baised eQTL |
| rs11764040 | chr7:1845194:G:C | - | 0.0600220724075921 | 0.0376113190323145 | COAD | Male-baised eQTL |
| rs7789581 | chr7:3026991:G:C | - | 0.0601831306162528 | 0.0384719099772411 | COAD | Male-baised eQTL |
| rs7803963 | chr7:3710107:T:C | - | 0.0987961328954877 | 0.0416404601185697 | COAD | Male-baised eQTL |
| rs6943054 | chr7:3658723:T:G | - | 0.0612843869114958 | 0.0422801895192048 | COAD | Male-baised eQTL |
| rs58673065 | chr7:1845964:A:G | - | 0.0589651279339976 | 0.0444578465202706 | COAD | Male-baised eQTL |
| rs1009115 | chr7:8395352:C:T | - | 0.0610298893577814 | 0.045179071224922 | COAD | Male-baised eQTL |
| rs2040768 | chr7:8522928:A:T | - | 0.0533747848933749 | 0.0475366899566176 | COAD | Male-baised eQTL |
| rs12216659 | chr7:11971224:T:C | - | 0.0520529515421326 | 0.0499660731141571 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000003147 |
| CpG Site: cg13394022 | |
| Position to Gene: promoter | |
| Male Effect: -0.398608261518707 | |
| Female Effect: - | |
 | Gene ID: ENSG00000003147 |
| CpG Site: cg26826957 | |
| Position to Gene: gene | |
| Male Effect: -0.18328951825488 | |
| Female Effect: - | |
 | Gene ID: ENSG00000003147 |
| CpG Site: cg14430015 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.105837904129126 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg13394022 | chr7:8263201 | promoter | -0.398608261518707 | 8.92087924270649e-06 | -0.5740799069473408 | 2.1061493459633413e-08 | PAAD |
| cg26826957 | chr7:8237182 | gene | -0.18328951825488 | 8.82551258835501e-06 | -0.3618164744364727 | 3.076568109959024e-08 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg14430015 | chr7:8176266 | gene | -0.105837904129126 | 8.31453578532855e-05 | -0.3564439142596668 | 9.715910856255754e-07 | SKCM |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ICA1 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
